Endocannabinoids and energy homeostasis: An update

被引:94
作者
Cristino, Luigia [1 ]
Becker, Thorsten [1 ,2 ]
Di Marzo, Vincenzo [1 ]
机构
[1] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80078 Pozzuoli, Italy
[2] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy
关键词
hypothalamus; leptin; retrograde neurotransmission; metabolic disfunctions; anti-obesity drugs; CANNABINOID CB1 RECEPTOR; VAGAL AFFERENT NEURONS; NERVOUS-SYSTEM CONTROL; BROWN ADIPOSE-TISSUE; FOOD-INTAKE; ANTAGONIST SR141716; BODY-WEIGHT; INSULIN; LEPTIN; RIMONABANT;
D O I
10.1002/biof.1168
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endocannabinoid system (ECS) is a widespread intercellular signaling system that plays a critical role in energy homeostasis, meant as the precise matching of caloric intake with energy expenditure which normally keeps body weight stable over time. Complex interactions between environmental and neurohormonal systems directly contribute to the balance of energy homeostasis. This review highlights established and more recent data on the brain circuits in which the ECS plays an important regulatory role, with focus on the hypothalamus, a region where numerous interacting systems regulating feeding, satiety, stress, and other motivational states coexist. Although not meant as an exhaustive review of the field, this article will discuss how endocannabinoid tone, in addition to reinforcing reward circuitries and modulating food intake and the salience of food, controls lipid and glucose metabolism in several peripheral organs, particularly the liver and adipose tissue. Direct actions in the skeletal muscle and pancreas are also emerging and are briefly discussed. This review provides new perspectives into endocannabinoid control of the neurochemical causes and consequences of energy homeostasis imbalance, a knowledge that might lead to new potential treatments for obesity and related morbidities. (C) 2014
引用
收藏
页码:389 / 397
页数:9
相关论文
共 88 条
[1]   Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice [J].
Bajzer, M. ;
Olivieri, M. ;
Haas, M. K. ;
Pfluger, P. T. ;
Magrisso, I. J. ;
Foster, M. T. ;
Tschoep, M. H. ;
Krawczewski-Carhuatanta, K. A. ;
Cota, D. ;
Obici, S. .
DIABETOLOGIA, 2011, 54 (12) :3121-3131
[2]   Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade [J].
Bellocchio, Luigi ;
Soria-Gomez, Edgar ;
Quarta, Carmelo ;
Metna-Laurent, Mathilde ;
Cardinal, Pierre ;
Binder, Elke ;
Cannich, Astrid ;
Delamarre, Anna ;
Haering, Martin ;
Martin-Fontecha, Mar ;
Vega, David ;
Leste-Lasserre, Thierry ;
Bartsch, Dusan ;
Monory, Krisztina ;
Lutz, Beat ;
Chaouloff, Francis ;
Pagotto, Uberto ;
Guzman, Manuel ;
Cota, Daniela ;
Marsicano, Giovanni .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (12) :4786-4791
[3]   Bimodal control of stimulated food intake by the endocannabinoid system [J].
Bellocchio, Luigi ;
Lafenetre, Pauline ;
Cannich, Astrid ;
Cota, Daniela ;
Puente, Nagore ;
Grandes, Pedro ;
Chaouloff, Francis ;
Piazza, Pier Vincenzo ;
Marsicano, Giovanni .
NATURE NEUROSCIENCE, 2010, 13 (03) :281-283
[4]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[5]   Presence of functional cannabinoid receptors in human endocrine pancreas [J].
Bermudez-Silva, F. J. ;
Suarez, J. ;
Baixeras, E. ;
Cobo, N. ;
Bautista, D. ;
Cuesta-Munoz, A. L. ;
Fuentes, E. ;
Juan-Pico, P. ;
Castro, M. J. ;
Milman, G. ;
Mechoulam, R. ;
Nadal, A. ;
de Fonseca, F. Rodriguez .
DIABETOLOGIA, 2008, 51 (03) :476-487
[6]   The role of the pancreatic endocannabinoid system in glucose metabolism [J].
Bermudez-Silva, Francisco J. ;
Perez, Juan Suarez ;
Nadal, Angel ;
Rodriguez de Fonseca, Fernando .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (01) :87-102
[7]   Development of the first potent and specific inhibitors of endocannabinoid biosynthesis [J].
Bisogno, T ;
Cascio, MG ;
Saha, B ;
Mahadevan, A ;
Urbani, P ;
Minassi, A ;
Appendino, G ;
Saturnino, C ;
Martin, B ;
Razdan, R ;
Di Marzo, V .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (02) :205-212
[8]  
Bisogno T., 2013, BRIT J PHARMACOL, V169, P748
[9]   Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol [J].
Bisogno, Tiziana ;
Burston, James J. ;
Rai, Ravi ;
Allara, Marco ;
Saha, Bijali ;
Mahadevan, Anu ;
Razdan, Raj K. ;
Wiley, Jenny L. ;
Di Marzo, Vincenzo .
CHEMMEDCHEM, 2009, 4 (06) :946-950
[10]   The Endocannabinoid 2-Arachidonoyl-Glycerol Controls Odor Sensitivity in Larvae of Xenopus laevis [J].
Breunig, Esther ;
Manzini, Ivan ;
Piscitelli, Fabiana ;
Gutermann, Benjamin ;
Di Marzo, Vincenzo ;
Schild, Detlev ;
Czesnik, Dirk .
JOURNAL OF NEUROSCIENCE, 2010, 30 (26) :8965-8973